Refine Results
- view as grid
- view as list
The Families First Coronavirus Response Act: Summary of Key Provisions
A summary of key provisions of the Families First Coronavirus Response Act that addresses the domestic coronavirus outbreak, including paid sick leave, insurance coverage of coronavirus testing, nutrition assistance, and unemployment benefits.
Breaking Down the U.S. Global Health Budget by Program Area
The U.S. government is the largest donor to global health in the world. This fact sheet breaks down the U.S. global health budget by program area: HIV/PEPFAR; tuberculosis (TB); malaria/the President’s Malaria Initiative (PMI); the Global Fund to Fight AIDS, Tuberculosis, and Malaria; maternal & child health (MCH); nutrition; family planning & reproductive health (FP/RH); global health security; and neglected tropical diseases (NTDs).
The U.S. Response to Coronavirus: Summary of the Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020
The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020, which was passed with near unanimous support in both the House and Senate, was signed into law by the President on March 6, 2020. The bill provides $8.3 billion in emergency funding for federal agencies to respond to the coronavirus outbreak. This summary provides details on funding specified in the bill.
The U.S. Government and Global Neglected Tropical Disease Efforts
This fact sheet examines the U.S. government’s role in addressing neglected tropical diseases (NTDs) worldwide.
The U.S. Government and Global Health Security
This brief examines the U.S. government’s efforts in global health security – that is, efforts to help countries prepare for and address pandemic and epidemic diseases such Ebola, Zika, and pandemic influenza. The brief provides history and background, reviews the U.S. agencies carrying out these efforts, reviews funding, and highlights key policy issues going forward.
A Look at Recent Proposals to Control Drug Spending by Medicare and its Beneficiaries
In response to higher drug spending growth and heightened attention to drug prices, policymakers have proposed a variety of policy initiatives to lower the cost of prescription drugs in Medicare. This brief examines in detail the range of proposals offered by the Trump Administration and members of Congress for lowering the cost of prescription drugs, their known effects on the federal budget, and their potential implications for beneficiaries and other stakeholders.
What’s the Latest on Medicare Drug Price Negotiations?
In response to higher drug spending growth and heightened attention to drug prices, some policymakers have proposed allowing Medicare to negotiate the price of prescription drugs. This issue brief provides a short history of this proposal, describes several bills introduced in the 116th Congress to allow government negotiations as well as assessments of potential savings from the Congressional Budget Office (CBO), and considers the prospects for action in the future.
The Millennium Challenge Corporation (MCC) and Global Health
This fact sheet describes the functions, governance, funding, and approach of the Millennium Challenge Corporation (MCC), with a particular focus on MCC’s engagement in global health.
The Facts on Medicare Spending and Financing
This issue brief examines the latest facts about Medicare spending and financing, including the most recent historical and projected Medicare spending data from the Centers for Medicare and Medicaid Services Office of the Actuary, the 2019 annual report of the Boards of Medicare Trustees, and the 2019 Medicare baseline and projections from the Congressional Budget Office. It discusses historical and projected spending trends, program financing, Medicare’s financial condition, and the future outlook.